Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 40 EP applications Emma Marie Bassinder has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 14, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11791692

4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS MGLUR 2/3 ANTAGONISTS

IPC classification:
A61K 31/10, C07C 323/58
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
The patent has been granted
EP11793573

4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS

IPC classification:
A61K 31/21, A61P 25/24, C07C 229/50
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP11813490

BOVINE VIRAL DIARRHEA VIRUS TYPE 1B VACCINE COMPOSITIONS AND METHODS

IPC classification:
A61K 39/12, A61P 31/14
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12704486

METHODS FOR CONTROLLING PAIN IN CANINES USING A TRANSDERMAL SOLUTION OF FENTANYL

IPC classification:
A61K 9/00, A61K 31/4468
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12704489

METHODS FOR CONTROLLING PAIN IN EQUINES USING A TRANSDERMAL SOLUTION OF FENTANYL

IPC classification:
A61K 9/00, A61K 31/4468, A61K 47/10, A61K 47/14
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12726226

SUBSTITUTED INDOLE DERIVATIVES FOR THE TREATMENT OF IMMUNOLOGICAL DISORDERS

IPC classification:
A61K 31/496, A61P 37/00, C07D 401/14, C07F 9/141
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12730766

FAST DISSOLVING AZAPERONE GRANULATE FORMULATION

IPC classification:
A61K 9/16, A61K 31/496, A61P 43/00
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP12748299

ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUBLE MONENSIN AND METHODS THEREFOR

IPC classification:
A23K 1/16, A23K 1/17, A23K 1/175, A23K 1/18
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12707629

ISOXAZOLE DERIVATIVES

IPC classification:
A01N 43/80, A01N 47/38, C07D 413/04, C07D 413/14, C07D 417/14, C07D 419/04
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12721146

PARASITICIDAL DIHYDROISOXAZOLE COMPOUNDS

IPC classification:
A01N 43/80, C07D 413/04, C07D 413/14, C07D 495/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13704563

SYSTEM FOR PROVIDING A LIQUID-SUBSTANCE MIXTURE ATTRACTIVE TO AN ANIMAL

IPC classification:
B65D 51/28, B65D 81/32
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP13706128

METHODS AND COMPOSITIONS FOR REDUCING THE ENVIRONMENTAL IMPACT OF ANIMAL WASTE

IPC classification:
A23K 1/165, A23K 1/18
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP13721733

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A01N 47/34, A61K 31/17, A61P 33/14
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP11728632

ANTIBIOTIC COMPOSITIONS

IPC classification:
A61K 9/19, A61K 31/7048, A61P 31/04, A61P 33/02
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP13779364

BICYCLIC HETEROARYL CYCLOALKYLDIAMINE DERIVATIVES AS INHIBITORS OF SPLEEN TYROSINE KINASES (SYK)

IPC classification:
A61K 31/5025, A61P 11/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13747376

SUBTITUTED AZINES AS PESTICIDES

IPC classification:
A01N 43/54, A01P 17/00, A61K 31/505, A61K 31/506, C07D 213/74, C07D 239/47, C07D 239/48, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/12, C07D 403/14, C07D 413/14, C07D 487/10
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP11745633

LAURIC ACID DISTILLATE FOR ANIMAL FEED

IPC classification:
A23K 1/16, A23K 1/18
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13785745

AGGRECANASE INHIBITORS

IPC classification:
A61K 31/4166, C07D 233/76
Applicant:
Eli Lilly and Company Limited
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
The patent has been granted
EP13799490

NEW TREATMENT

IPC classification:
A01N 51/00
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12704356

MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS

IPC classification:
A61K 31/439, A61K 31/4995, A61P 31/14, C07D 471/18, C07D 471/22, C07D 498/22, C07D 513/18, C07D 515/18
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13814903

AN ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASE

IPC classification:
A61K 33/26, A61P 7/06
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815504

(HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES

IPC classification:
A01N 37/18, A01N 43/04, A01N 43/08, A01N 43/10, A01N 43/40
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP14712939

1 -HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS

IPC classification:
A01N 43/00, C07F 5/02
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
The patent has been granted
EP11740921

COMPOUNDS WITH ANTIBACTERIAL ACTIVITY AGAINST CLOSTRIDIUM

IPC classification:
A61K 31/53, A61P 31/04, C07D 487/04
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11788268

METHODS FOR INHIBITING INSECT INFESTATIONS

IPC classification:
A01N 43/22, A01P 7/04, A61K 31/7048
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11764063

FORMULATIONS FOR BOVINE GRANULOCYTE COLONY STIMULATING FACTOR AND VARIANTS THEREOF

IPC classification:
A61K 38/19, A61P 29/00, C07K 14/535
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14733933

PARASITICIDAL COMPOUNDS, METHODS, AND FORMULATIONS

IPC classification:
A61K 31/7048, A61P 33/00, C07H 17/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP15193269

NEW COMBINATION

IPC classification:
A61K 9/20, A61K 31/4184, A61K 31/501, A61K 47/12
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP11787778

3-SUBSTITUTED-6-(PYRIDINYLMETHOXY)-PYRROLOPYRIDINE COMPOUNDS

IPC classification:
A61K 31/437, A61P 25/16, C07D 471/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11709952

ENDOPARASITICIDAL COMPOSITIONS

IPC classification:
A01N 37/34, A01N 43/90, A61K 31/277, A61P 33/00
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP12704256

ISOXAZOLINE DERIVATIVES FOR CONTROLLING INVERTEBRATE PESTS

IPC classification:
A01N 43/84, A01N 47/24
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP11771312

CRYSTALLINE (R)-(E)-2-(4-(2-(5-(1-(3,5-DICHLOROPYRIDIN-4-YL)ETHOXY)-1H-INDAZOL-3-YL)VINYL)-1H-PYRAZOL-1-YL)ETHANOL AND ITS USE AS FGFR INHIBITOR

IPC classification:
A61K 31/4439, A61P 35/00, C07D 401/14
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14801989

New Compounds

IPC classification:
C07D 211/58, C07D 213/74, C07D 239/42, C07D 401/06, C07D 401/10, C07D 401/14, C07D 487/10
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP11791146

OXAZOLO[5,4-B]PYRIDIN-5-YL COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/424, A61K 31/437, C07D 413/12, C07D 498/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16188388

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A01N 47/34, A61K 9/50, A61K 31/17, A61P 33/14, A23K 50/80, A23K 20/105
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15731204

TRANSDERMAL FORMULATIONS OF PERGOLIDE AND USES THEREOF

IPC classification:
A61K 9/08, A61K 31/48, A61K 47/10, A61K 47/14, A61K 47/16, A61K 47/20, A61K 47/22, A61K 47/40
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15760581

NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS

IPC classification:
A61K 31/18, A61P 33/10, C07C 205/11, C07C 311/08, C07C 311/20, C07D 213/61
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15797744

DIARYL ISOXAZOLINE COMPOUND

IPC classification:
A01N 43/80, A01P 17/00, C07D 413/04
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15805005

ANTIVIRAL EFFECTS OF NARASIN IN SWINE FEED

IPC classification:
A61K 31/351, A61P 1/12
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15801597

1,2-BENZOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF KIDNEY DISORDERS

IPC classification:
A61K 31/428, A61P 3/10, A61P 13/12, C07D 417/06
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made

Please Sign in to use this feature